Domain- and task-specific transfer learning for medical segmentation tasks.

Background and Objectives: Transfer learning is a valuable approach to perform medical image segmentation in settings with limited cases available for training convolutional neural networks (CNN). Both the source task and the source domain influence transfer learning performance on a given target medical image segmentation task. This study aims to assess transfer learning-based medical segmentation task performance for various source task and domain combinations.
Methods: CNNs were pre-trained on classification, segmentation, and self-supervised tasks on two domains: natural images and T1 brain MRI. Next, these CNNs were fine-tuned on three target T1 brain MRI segmentation tasks: stroke lesion, MS lesions, and brain anatomy segmentation. In all experiments, the CNN architecture and transfer learning strategy were the same. The segmentation accuracy on all target tasks was evaluated using the mIOU or Dice coefficients. The detection accuracy was evaluated for the stroke and MS lesion target tasks only.
Results: CNNs pre-trained on a segmentation task on the same domain as the target tasks resulted in higher or similar segmentation accuracy compared to other source task and domain combinations. Pre-training a CNN on ImageNet resulted in a comparable, but not consistently higher lesion detection rate, despite the amount of training data used being 10 times larger.
Conclusions: This study suggests that optimal transfer learning for medical segmentation is achieved with a similar task and domain for pre-training. As a result, CNNs can be effectively pre-trained on smaller datasets by selecting a source domain and task similar to the target domain and task.
Competing Interests: Declaration of Competing Interest This publication is based on the STAIRS project under the TKI-PPP program. The collaboration project is co-funded by the PPP Allowance made available by Health-Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. Dr. H.A. Marquering is a cofounder and shareholder of Nico.Lab. Dr. M.W.A. Caan is shareholder of Nico.Lab.
(Copyright © 2021 Elsevier B.V. All rights reserved.)